Indoco Remedies has reported results for third quarter ended December 31, 2022.
The company has reported fall of 15.47% in its net profit at Rs 27.87 crore for Q3FY23 as compared to Rs 32.97 crore for the corresponding quarter previous year. However, total income of the company increased by 11.48% to Rs 399.01 crore for the quarter under review as compared to Rs 357.92 crore for the same quarter in the previous year.
On the consolidated basis, the company has reported fall of 14.70% in its net profit at Rs 28.14 crore for Q3FY23 as compared to Rs 32.99 crore for the same quarter in the previous year. However, total income of the company increased by 11.56% to Rs 399.56 crore for the quarter under review as compared to Rs 358.16 crore for the same quarter in the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1486.55 |
Dr. Reddys Lab | 5860.25 |
Cipla | 1482.55 |
Zydus Lifesciences | 1072.35 |
Lupin | 1613.65 |
View more.. |